Cargando…

Advances in the treatment of secondary and tertiary hyperparathyroidism

Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple or...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li-Xi, Zhang, Ben, Liu, Xu-Yao, Wang, Zi-Ming, Qi, Peng, Zhang, Tong-Yue, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763452/
https://www.ncbi.nlm.nih.gov/pubmed/36561571
http://dx.doi.org/10.3389/fendo.2022.1059828
Descripción
Sumario:Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple organs and systems occur throughout the body due to hyperactivity disorder in SHPT and THPT. This not only decreases the patients’ quality of life, but also affects mortality. Since current treatments for these diseases remains unclear, we aimed to develop a comprehensive review of advances in the treatment of SHPT and THPT according to the latest relevant researches.